The Hematology Podcast

Sanofi
  • 5,0 (2)
  • ЗДОРОВЬЕ И ФИТНЕС
  • ЕЖЕМЕСЯЧНО
The Hematology Podcast

In The Hematology Podcast, we dig into the clinical, the theoretical, and the practical, as we discuss the past, present, and future of the hematological field. MAT-DK-2100201(1.0) March 2021

  1. 3 ОКТ.

    Decoding Multiple Myeloma genetic profile: The Power of Liquid Biopsy-Derived DNA

    In this episode, we dive into the fascinating world of liquid biopsy-derived DNA as a revolutionary tool for comprehensive mutation profiling in multiple myeloma. This innovative approach offers a non-invasive way to analyse genetic alterations, potentially transforming how we diagnose and monitor this complex hematological cancer. Join us as we explore the promises and challenges of using liquid biopsies to decode the genetic landscape of multiple myeloma and its implications for personalize...

    21 мин.

  2. 3 ОКТ.

    Transfusion Dependent Thalassemia - the Severe Spectrum

    In this episode, we focus on a severe form of Thalassemia known as Thalassemia major. In a previous episode, we discussed Thalassemia minor and intermedia with Professor Dr. Bart Biemond from Amsterdam UMC. Today, we’ll delve deeper into the challenges and treatments associated with Thalassemia major. Prof. Biemond is still with us to share his expertise. ASSET-24016319 (ver. 2.0) Oct 2024

    44 мин.

  3. 24 ФЕВР.

    AML - from basics to future prospectives

    Acute myeloid leukemia (AML) is a hematopoietic stem cell-derived myeloid malignancy characterized by manifold genetic aberrations and poor overall survival. Standard treatment for newly diagnosed fit AML patients is intensive chemotherapy. Relapse is, however, a challenge in more than 40% of AML patients. AML is also a disease with a large degree of individual heterogeneity, which creates challenges both for diagnostics and for developing targeted treatment options. Our guest is Björn G...

    31 мин.

  4. 7 ФЕВР.

    Smoldering Multiple Myeloma – to treat or not to treat?

    Smoldering multiple myeloma (SMM) is an intermediate condition that lies between Monoclonal gammopathy of undetermined significance (MGUS) and active multiple myeloma along the spectrum of clonal plasma cell proliferative disorders. Smoldering multiple myeloma may take years to become active multiple myeloma. In some cases, people who have this condition never develop active multiple myeloma. In this episode we have the pleasure of having the Norwegian haematologist Fredrik Schjesvold wi...

    26 мин.

  5. 2 ФЕВР.

    Thalassemia - a blind spot

    Thalassemia is a hereditary blood disorder, in which the synthesis of hemoglobin chains is impaired. Consequently, people with thalassemia minor may have slight to severe anemia which usually does not cause any problems. Thalassemia major in contrast is a severe disorder with need of transfusion and complications with iron overload. In this episode we will mainly discuss thalassemia minor and intermedia. Our guest today Professor Bart Biemond is a hematologist at the Amsterdam UMC ...

    41 мин.

  6. 31.10.2023

    Causes, symptoms and diagnosing ASMD – A rare lysosomal storage disorder

    Today we will discuss a rare, inherited metabolic disorder known as ASMD, acid sphingomyelinase deficiency (or historically known as Niemann-Pick types A, A/B, and B). This genetic condition is very rare. It can be diagnosed, after suspicion, by different screening test. But symptoms may vary greatly, and has overlap with several other disorders, and the road to an accurate diagnosis can therefore be challenging. In today’s episode we have the pleasure of welcoming Professor David Cassim...

    38 мин.

  7. 26.10.2023

    MGRS- Monoclonal Gammopathy of Renal Significance

    Monoclonal gammopathy of renal significance (MGRS) is a hemato-nephrological term referring to a heterogeneous group of kidney disorders characterized by direct or indirect kidney injury caused by a monoclonal immunoglobulin (MIg) produced by a B cell or plasma cell clone that does not meet current hematologic criteria for therapy. MGRS-associated kidney diseases are diverse and can result in the development of end stage kidney disease (ESKD). In this episode we have the pleasure of having th...

    26 мин.

  8. 07.07.2023

    Sickle cell disease - A hereditary blood disorder

    Sickle cell disease (SCD) is a hereditary blood disorder, where red blood cells have the shape of a C or sickle - hence the name. Sickle cells have a shorter lifespan than normal red blood cells, which causes anemia. Additionally, sickle cells may block blood vessels, especially during infections, dehydration, stress or fatigue, causing complications for the patients. Our guest today Professor Bart Biemond is a haematologist at the Amsterdam UMC in The Netherlands. Bart is head of the He...

    1 ч. 3 мин.
См. все (20)

Оценки и отзывы

5
из 5
Оценок: 2

Об этом подкасте

In The Hematology Podcast, we dig into the clinical, the theoretical, and the practical, as we discuss the past, present, and future of the hematological field. MAT-DK-2100201(1.0) March 2021

Информация

  • Автор
    Sanofi
  • Годы выхода
    2021 - 2024
  • Выпуски
    20
  • Ограничения
    Без ненормативной лексики
  • Авторские права
    © 2024 Sanofi
  • Сайт подкаста
    The Hematology Podcast

Вам может также понравиться

Чтобы прослушивать выпуски с ненормативным контентом, войдите в систему.

Следите за новостями подкаста

Войдите в систему или зарегистрируйтесь, чтобы следить за подкастами, сохранять выпуски и получать последние обновления.
Выберите страну или регион

Африка, Ближний Восток и Индия

Азиатско-Тихоокеанский регион

Европа

Латинская Америка и страны Карибского бассейна

США и Канада